Company intelligence / Profile preview

MBiotec

Suwon, Gyeonggi-do, South Korea

Ownership: Private
Development stage: Other

Overview

MBiotec is a South Korean biotechnology company specializing in the development and manufacture of advanced biomaterials and medical devices for regenerative medicine. The company focuses on utilizing collagen and other biocompatible materials to create products for wound care, tissue engineering, and orthopedic applications. Their portfolio includes collagen-based wound dressings and injectable fillers designed to promote natural healing processes. MBiotec aims to provide innovative solutions for chronic wounds and musculoskeletal disorders through rigorous research and high-quality manufacturing standards.

Therapeutic areas: RheumatologyDermatology
Modalities: BiologicSmall moleculeMedical Device
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on MBiotec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MBiotec.

Explore the full profile